Collegium Pharmaceutical (COLL)
(Delayed Data from NSDQ)
$34.25 USD
+0.43 (1.27%)
Updated May 24, 2024 04:00 PM ET
After-Market: $34.26 +0.01 (0.03%) 7:58 PM ET
3-Hold of 5 3
A Value B Growth B Momentum A VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/01/2024
Time: -- |
6/2024 | $1.46 | 0.05% |
Earnings Summary
For their last quarter, Collegium Pharmaceutical (COLL) reported earnings of $1.45 per share, missing the Zacks Consensus Estimate of $1.49 per share. This reflects a negative earnings surprise of 2.68%. Look out for COLL's next earnings release expected on August 01, 2024. For the next earning release, we expect the company to report earnings of $1.46 per share, reflecting a year-over-year increase of 15.87%.
Earnings History
Price & Consensus
Zacks News for COLL
Collegium Pharmaceutical (COLL) Q1 Earnings and Revenues Lag Estimates
COLL: What are Zacks experts saying now?
Zacks Private Portfolio Services